Mankind Pharma Shows Resilience with Consecutive Gains Amid Market Fluctuations

Mankind Pharma has shown notable activity today, gaining 3.03% on March 27, 2025. The stock has outperformed its sector by 3.53%, marking a positive trend as it has experienced consecutive gains over the last three days, resulting in a total return of 4.76% during this period. The stock reached an intraday high of Rs 2490, reflecting a robust performance amidst a fluctuating market environment.
In the broader market, the Sensex initially opened lower but rebounded sharply, currently trading at 77,606.43, up 0.41%. Mankind Pharma's performance over various time frames indicates resilience, with a 1-week gain of 9.56% compared to the Sensex's 1.65%. However, over the past three months, Mankind Pharma has faced a decline of 14.21%, contrasting with the Sensex's smaller drop of 1.39%.

The stock's moving averages indicate it is currently above the 5-day, 20-day, 50-day, and 200-day averages, although it remains below the 100-day moving average. This performance reflects Mankind Pharma's position within the large-cap pharmaceuticals and drugs industry, highlighting its recent upward momentum amidst broader market trends.